Quantbot Technologies
RXDX

Quantbot Technologies’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Quantbot Technologies’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,158
Closed -$145K – 2240
2022
Q2 		$145K Buy
5,158
+4,738
+1,128% +$137K 0.01% 1035
2022
Q1 		$15K Buy
+420
New +$16.6K ﹤0.01% 1416

Other funds holding RXDX

RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Cormorant Asset Management
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return
Boxer Capital
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CHI Advisors
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Quantbot Technologies's RXDX Position: Q3 2022 in Review

Quantbot Technologies sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q3 2022, closing a stake of 5,158 shares — an estimated $145K sold.

Quantbot Technologies first reported a position in RXDX in Q1 2022 and held it in 2 quarters. The position peaked at $145K in Q2 2022. 144 funds tracked by Wall St. Rank hold RXDX as of Q3 2022.

  • Quantbot Technologies reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Quantbot Technologies sold 5,158 Prometheus Biosciences, Inc. Common Stock shares in Q3 2022, an estimated $145K.
  • Quantbot Technologies first reported a position in Prometheus Biosciences, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Quantbot Technologies's Prometheus Biosciences, Inc. Common Stock position peaked at $145K in Q2 2022.
  • 144 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q3 2022.

Based on Quantbot Technologies's 13F filing for Q3 2022, filed 7 Nov 2022.